NigelMartynBarkMD
Psychiatry • Orangeburg, NYAssociate Professor, Psychiatry & Behavioral Sciences, Albert Einstein College of Medicine
Are you Dr. Bark?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 7 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
117 Constitution Dr
Orangeburg, NY 10962Phone+1 845-359-7553Fax+1 845-359-7553
Summary
- Dr. Nigel Bark, MD is a board certified psychiatrist in Orangeburg, New York. He is currently licensed to practice medicine in New York and New Jersey. He is an Associate Professor at Albert Einstein College of Medicine.
Education & Training
University of Cambridge School of MedicineClass of 1966
Certifications & Licensure
NJ State Medical License Current
NY State Medical License 1976 - 2026- American Board of Psychiatry and Neurology Psychiatry
Clinical Trials
- Efficacy and Tolerability of Switching to Ziprasidone From Other Antipsychotics Start of enrollment: 2005 May 01
- An Open Trial of Allopurinol in Patients With Poorly Responsive Schizophrenia Start of enrollment: 2005 Nov 01
- Study of Vitamin D in the Severely Mentally Ill Start of enrollment: 2010 Jan 01
Publications & Presentations
PubMed
- 204 citationsAtypical antipsychotic agents in the treatment of violent patients with schizophrenia and schizoaffective disorderMenahem I. Krakowski, Pál Czobor, Leslie Citrome, Nigel Bark, Thomas B. Cooper
Archives of General Psychiatry. 2006-06-01 - 128 citationsAdjunctive high-dose glycine in the treatment of schizophrenia.Daniel C. Javitt, Gail Silipo, Angel Cienfuegos, Anne Marie Shelley, Nigel Bark
The International Journal of Neuropsychopharmacology. 2001-12-01 - 34 citationsEffects of pioglitazone on metabolic abnormalities, psychopathology, and cognitive function in schizophrenic patients treated with antipsychotic medication: A randomiz...Robert C. Smith, Hua Jin, Chunbo Li, Nigel Bark, Anantha Shekhar
Schizophrenia Research. 2013-01-01
Authored Content
- Hydroxychloroquine - Does It Have Clinical Value in COVID-19? A Point, Counterpoint DiscussionNovember 2020
